The effects of intravenous doxycycline therapy for rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial

Arthritis and Rheumatism

Volumn 44, Issue 5, 2001, Pages 1043-1047

  St Clair, E William ^a   Wilkinson, William E ^a   Pisetsky, David S ^a   Sexton, Daniel J ^a   Drew, Richard ^a,b   Kraus, Virginia B ^a   Greenwald, Robert A ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Campbell University   (United States)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; PLACEBO; PYRIDINOLINE; RHEUMATOID FACTOR;

ABDOMINAL PAIN; ADULT; ANOREXIA; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLLAGEN DEGRADATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS LINKING; DIARRHEA; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; HEADACHE; HUMAN; INFUSION; MALE; NAUSEA AND VOMITING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; URINARY EXCRETION; VAGINITIS; VERTIGO;

ADULT; AMINO ACIDS; ANTI-BACTERIAL AGENTS; ARTHRITIS, RHEUMATOID; AZITHROMYCIN; COLLAGEN; DOUBLE-BLIND METHOD; DOXYCYCLINE; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PATIENT DROPOUTS;

EID: 0035038882     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200105)44:5<1043::AID-ANR183>3.0.CO;2-C     Document Type: Article

References (15)

1. Kloppenburg M, Breedveld FC, Terwiel J, Mallee C, Dijkmans BAC. Minocycline in active rheumatoid arthritis: a double-blind, placebo-controlled trial. Arthritis Rheum 1994;37:629-36.
2. Tilley BC, Alarcón GS, Heyse SP, Trentham DE, Neuner R, Kaplan DA, et al., for the MIRA Trial Group. Minocycline in rheumatoid arthritis: a 48-week, double-blind, placebo-controlled trial. Ann Intern Med 1995;122:81-9.
3. O'Dell JR, Haire CE, Palmer W, Drymalski W, Wees S, Blakely K, et al. Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1997;40:842-8.
4. Greenwald RA. Monitoring collagen degradation in patients with arthritis: the search for suitable surrogates. Arthritis Rheum 1996;39:1455-65.
5. St.Clair EW, Moak SA, Wilkinson WE, Sanders L, Lang T, Greenwald RA. A cross sectional analysis of 5 different markers of collagen degradation in rheumatoid arthritis. J Rheumatol 1998; 25:1472-9.
6. Johansen JS, Jensen HS, Price PA. A new biochemical marker for joint injury: analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol 1993;32:949-55.
7. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
8. Golub LM, Wolff M, Lee HM, McNamara TF, Ramamurthy NS, Zambon J, et al. Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources. J Periodontal Res 1985;20:12-23.
9. Greenwald RA, Golub LM, Lavietes B, Ramamurthy NS, Gruber B, Laskin RS, et al. Tetracyclines inhibit human synovial collagenase in vivo and in vitro. J Rheumatol 1987;14:23-8.
10. Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983;26:1346-53.
11. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
12. Van der Laan WH, Molenaar ET, Verheijen JH, Breedveld FC, Dijkmans BAC, te Koppele JM, et al. Doxycycline has no effect on disease activity or joint destruction in rheumatoid arthritis: a double-blind placebo-controlled study [abstract]. Arthritis Rheum 2000;43 Suppl 9:S345.
13. Golub LM, Lee HM, Greenwald RA, Ryan ME, Sorsa T, Salo T, et al. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res 1997; 46:310-9.
14. Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, et al. A novel mechanism of action of tetracyclines: effects on nitric oxide synthesis. Proc Natl Acad Sci U S A 1996;93:14014-9.
15. Ritchlin CT, Haas-Smith SA, Schwarz EM, Greenwald RA. Minocycline but not doxycycline upregulates IL-10 production in human synoviocytes, mononuclear cells and synovial explants [abstract]. Arthritis Rheum 2000;43 Suppl 9:S345.